Jiangsu Recbio (2179) Announces Updated Committee Terms of Reference

Bulletin Express12-01

Jiangsu Recbio Technology Co., Ltd. (Stock code: 2179) published revised terms of reference for its Board’s Remuneration and Appraisal Committee. The document outlines the committee’s role in formulating performance appraisal standards for directors and senior management, recommending remuneration plans, and overseeing satisfactory implementation of the company’s compensation system.

The new guidelines confirm that the committee must comprise at least three directors, with most members serving as independent non-executive directors. The committee’s scope includes annual performance reviews, monitoring remuneration structures, and ensuring compliance with regulatory requirements. The document also specifies procedures for convening meetings, the decision-making process, and the allocation of resources for fulfilling the committee’s responsibilities. Any resolutions passed by the Remuneration and Appraisal Committee will be reported to the Board for final review and approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment